grant
National Institutes of Health
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Source: grants.gov CFDA: Status: posted Lifecycle: modified
Eligibility
See opportunity for details